scholarly journals Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells.

1993 ◽  
Vol 91 (4) ◽  
pp. 1367-1373 ◽  
Author(s):  
Y Hirata ◽  
T Emori ◽  
S Eguchi ◽  
K Kanno ◽  
T Imai ◽  
...  
1993 ◽  
Vol 265 (1) ◽  
pp. C188-C192 ◽  
Author(s):  
M. Clozel ◽  
B. M. Loffler ◽  
V. Breu ◽  
L. Hilfiger ◽  
J. P. Maire ◽  
...  

The potent vasoconstrictor endothelin-1 (ET-1) is a paracrine, but also autocrine, factor for some types of cells. The goal of our study was to evaluate whether the receptor population in cells expressing endothelin receptor subtype A (rat mesangial cells) or endothelin receptor subtype B (human and rat endothelial cells) was affected by the autocrine production of ET-1. We therefore studied maximal binding capacity of 125I-labeled ET-1 in the presence or absence of the metalloprotease inhibitors phosphoramidon, which blocks the intracellular processing of Big ET-1 to ET-1, and thiorphan, which does not block this conversion. Phosphoramidon inhibited the release of ET-1 by human umbilical vein endothelial cells, rat aortic endothelial cells, and rat mesangial cells, and increased 1.4- to 17-fold the maximal binding capacity in the three types of cells. Thiorphan affected neither ET-1 release nor binding. The increase in receptor binding by phosphoramidon was associated with an increase in the functional effect of ET-1, as measured by arachidonic acid release in rat mesangial cells. We conclude that autocrine production of ET-1 decreases, either by binding or by downregulation, the number of binding sites available for ET-1 of paracrine or systemic sources. This aspect of modulation of the vasoconstrictor effect of endothelin should be considered in pathological situations or after endothelin-converting-enzyme inhibition.


1995 ◽  
Vol 270 (12) ◽  
pp. 6997-7003 ◽  
Author(s):  
Shigeki Iwasaki ◽  
Toshio Homma ◽  
Yuzuru Matsuda ◽  
Valentina Kon

Endocrinology ◽  
1999 ◽  
Vol 140 (3) ◽  
pp. 1301-1309 ◽  
Author(s):  
Marc Thibonnier ◽  
Doreen M. Conarty ◽  
Judy A. Preston ◽  
Christine L. Plesnicher ◽  
Raed A. Dweik ◽  
...  

Abstract Pharmacological studies in humans and animals suggest the existence of vascular endothelial vasopressin (AVP)/oxytocin (OT) receptors that mediate a vasodilatory effect. However, the nature of the receptor subtype(s) involved in this vasodilatory response remains controversial, and its coupled intracellular pathways are unknown. Thus, we set out to determine the type and signaling pathways of the AVP/OT receptor(s) expressed in human vascular endothelial cells (ECs). Saturation binding experiments with purified membranes of primary cultures of ECs from human umbilical vein (HUVEC), aorta (HAEC), and pulmonary artery (HPAEC) and [3H]AVP or[ 3H]OT revealed the existence of specific binding sites with a greater affinity for OT than AVP (Kd = 1.75 vs. 16.58 nm). Competition binding experiments in intact HUVECs (ECV304 cell line) with the AVP antagonist[ 125I]4-hydroxyphenacetyl-d-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-NH2 or the OT antagonist[ 125I]d(CH2)5[O-Me-Tyr-Thr-Orn-Tyr-NH2]vasotocin, and various AVP/OT analogs confirmed the existence of a single class of surface receptors of the classical OT subtype. RT-PCR experiments with total RNA extracted from HUVEC, HAEC, and HPAEC and specific primers for the human V1 vascular, V2 renal, V3 pituitary, and OT receptors amplified the OT receptor sequence only. No new receptor subtype could be amplified when using degenerate primers. DNA sequencing of the coding region of the human EC OT receptor revealed a nucleotide sequence 100% homologous to that of the uterine OT receptor reported previously. Stimulation of ECs by OT produced mobilization of intracellular calcium and the release of nitric oxide that was prevented by chelation of extra- and intracellular calcium. No stimulation of cAMP or PG production was noted. Finally, OT stimulation of ECs led to a calcium- and protein kinase C-dependent cellular proliferation response. Thus, human vascular ECs express OT receptors that are structurally identical to the uterine and mammary OT receptors. These endothelial OT receptors produce a calcium-dependent vasodilatory response via stimulation of the nitric oxide pathway and have a trophic action.


1988 ◽  
Vol 151 (1) ◽  
pp. 19-25 ◽  
Author(s):  
M. Gabriella Doni ◽  
Brendan J.R. Whittle ◽  
Richard M.J. Palmer ◽  
Salvador Moncada

Biochemistry ◽  
2000 ◽  
Vol 39 (4) ◽  
pp. 686-692 ◽  
Author(s):  
Fumiaki Imamura ◽  
Ikuyo Arimoto ◽  
Yoshinori Fujiyoshi ◽  
Tomoko Doi

2008 ◽  
Vol 86 (8) ◽  
pp. 499-504 ◽  
Author(s):  
H. Morawietz ◽  
A.H. Wagner ◽  
M. Hecker ◽  
W. Goettsch

In vivo, endothelial cells are constantly exposed to shear stress by flowing blood. Short-term exposure of endothelial cells to shear stress has been shown to induce endothelin-1 release. It is currently unknown, however, whether this shear stress-dependent endothelin-1 release affects the expression and activity of transcription factors. In this study, primary cultures of human endothelial cells from the umbilical vein were exposed to laminar shear stress in a cone-and-plate viscometer. Laminar shear stress for 30 min induced a 2-fold increase in mRNA expression of c-jun , but not c-fos, in human endothelial cells. Blockade of endothelin receptor subtype B (ETB) with BQ788 prevented this shear stress-dependent induction of c-jun expression. The induction of c-jun by shear stress involved protein kinase C and endothelial NO synthase. In addition, exposure of endothelial cells to arterial laminar shear stress for 1 h increased the binding of transcription factor AP-1 to its consensus sequence by 1.7-fold in electrophoretic mobility shift assays. This induction was also mediated by an ETB-dependent pathway. Supershift analysis supports an AP-1 complex containing c-jun, but not c-fos, in human endothelial cells. In conclusion, our data suggest endothelin-1-mediated induction of c-jun expression and activation of AP-1 (possibly as a c-jun homodimer) by laminar shear stress in human endothelial cells.


Sign in / Sign up

Export Citation Format

Share Document